Phages are viruses that kill bacteria
but are otherwise harmless. A major advantage is that phages only target the
harmful bacteria, so there are less side of the effects often associated with
antibiotics. Phage therapy however has not had the same level of funding as
drug development, due to a lack of convincing pre-clinical efficacy studies.
Researchers have shown that phage
therapy is highly effective in treating established and recalcitrant chronic
respiratory tract infections caused by multi-drug resistant Pseudomonas aeruginosa strains. They
show that phages are capable of killing the bacteria in long term infected
lungs, such as those suffered by patients with the inherited disease Cystic
Fibrosis, indicating a potential new therapeutic option for these hard to treat
life threatening infections.
For
further information see:
Elaine M Waters, Daniel R Neill, Basak
Kaman, Jaspreet S Sahota, Martha R J Clokie, Craig Winstanley, Aras Kadioglu. Phage therapy is highly
effective against chronic lung infections with Pseudomonas aeruginosa. Thorax, 2017;
thoraxjnl-2016-209265 DOI: 10.1136/thoraxjnl-2016-209265
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources